In progressive tumor tissues, the genes most frequently affected by GMs, SMs, or CNVs were androgen receptor (AR) (52.4% of patients), TP53 (46.0%), RB1 (34.9%), FOXA1 (31.7%), and PTEN (25.4%; Fig. 1B). Here, FOXA1 is linked to neoplasm.